127 related articles for article (PubMed ID: 4303116)
1. D-5-Chloro-2-(alpha-hydroxybenzyl) benzimidazole and 1-alkyl-5-chloro-2-(alpha-hydroxybenzyl) benzimidazoles as inhibitors of poliovirus multiplication.
O'Sullivan DG; Pantic D; Wallis AK
Experientia; 1968 Jul; 24(7):661-3. PubMed ID: 4303116
[No Abstract] [Full Text] [Related]
2. Patterns of cytopathology and lysosomal enzyme release in poliovirus-infected HEp-2 cells treated with either 2-(alpha-hydroxybenzyl)-benzimidazole or guanidine HCl.
Guskey LE; Smith PC; Wolff DA
J Gen Virol; 1970 Jan; 6(1):151-61. PubMed ID: 4313397
[No Abstract] [Full Text] [Related]
3. Inhibition of poliovirus by effect of a methylthiopyrimidine derivative.
Yamazi Y; Takahashi M; Todome Y
Proc Soc Exp Biol Med; 1970 Feb; 133(2):674-7. PubMed ID: 4313152
[No Abstract] [Full Text] [Related]
4. Antiviral properties of 1-allyl and 1-crotyl derivatives of 2-( -hydroxybenzyl) benzimidazole.
O'Sullivan DG; Ludlow CM
Experientia; 1972 Aug; 28(8):889-90. PubMed ID: 4342512
[No Abstract] [Full Text] [Related]
5. Structural requirements of selective inhibition of enteroviruses by 2-(alpha-hydroxybenzyl)-benzimidazole and related compounds.
Tamm I; Eggers HJ; Bablanian R; Wagner AF; Folkers K
Nature; 1969 Aug; 223(5208):785-8. PubMed ID: 5799019
[No Abstract] [Full Text] [Related]
6. Relationship between structure of benzimidazole derivatives and selective virus inhibitory activity. Inhibition of poliovirus multiplication and cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole, and its 5-chloroderivative.
TAMM I; BABLANIAN R; NEMES MM; SHUNK CH; ROBINSON FM; FOLKERS K
J Exp Med; 1961 Apr; 113(4):625-56. PubMed ID: 13775109
[TBL] [Abstract][Full Text] [Related]
7. Alkylated pyrimidine derivatives as antiviral agents. II. Inhibition of early stages of viral multiplication by 5-alkyluracil and 5-alkyluracil nucleoside.
Muraoka M; Seto Y; Ueda T
Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):269-74. PubMed ID: 4314620
[No Abstract] [Full Text] [Related]
8. Inhibition of lymphocytic choriomeningitis virus multiplication by 2-(alpha-hydroxybenzyl)benzimidazole.
Pfau CJ; Camyre KP
Virology; 1968 Jul; 35(3):375-80. PubMed ID: 4969540
[No Abstract] [Full Text] [Related]
9. Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro.
Siegl G; Eggers HJ
J Gen Virol; 1982 Jul; 61 (Pt l)():111-4. PubMed ID: 6288846
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity and molecular features of benzimidazoles.
O'Sullivan DG; Ludlow C; Pantic D; Wallis AK
Antimicrob Agents Chemother (Bethesda); 1969; 9():153-9. PubMed ID: 4319306
[No Abstract] [Full Text] [Related]
11. Loganin from Mytragyna parvifolia Korth.
O'Sullivan DG; Pantic D; Wallis AK
Experientia; 1968 Dec; 24(12):1185-7. PubMed ID: 4302873
[No Abstract] [Full Text] [Related]
12. [Antiviral activity of benzimidazole derivatives. I. Synthesis and antiviral activity of hydroxyalkylbenzimidazole derivatives].
Akihama S; Okude M; Sato K; Iwabuchi S
Yakugaku Zasshi; 1968 Jun; 88(6):684-9. PubMed ID: 4302743
[No Abstract] [Full Text] [Related]
13. [Effect of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine on the activity of RNA polymerases, induced by encephalomyocarditis viruses and poliovirus].
Dmitrieva TM; Tol'skaia EA; Senkevich TG; Agol VI
Dokl Akad Nauk SSSR; 1972 Sep; 206(2):486-9. PubMed ID: 4343925
[No Abstract] [Full Text] [Related]
14. [Studies of benzimidazole derivatives. XIII. Synthesis of various 2-alpha-hydroxy- and 2-beta-hydroxyalkyl-benzimidazoles].
Saczewski F; Foks H; Sawlewicz J; Szulc K
Acta Pol Pharm; 1986; 43(4):299-307. PubMed ID: 3028045
[No Abstract] [Full Text] [Related]
15. New 1,2-disubstituted benzimidazoles with high inhibiting effects on poliovirus replication.
O'Sullivan DG; Pantic D; Wallis AK
Experientia; 1967 Sep; 23(9):704-6. PubMed ID: 4294135
[No Abstract] [Full Text] [Related]
16. Interference with cell viability and poliovirus multiplication by polyinosinic--polycytidylic acid.
Flikke M; Kjeldsberg E; Lahelle O
J Gen Virol; 1970 Nov; 9(2):111-7. PubMed ID: 4320688
[No Abstract] [Full Text] [Related]
17. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication.
Nikolaeva L; Galabov AS
Acta Virol; 1995 Dec; 39(5-6):235-41. PubMed ID: 8722291
[TBL] [Abstract][Full Text] [Related]
19. [Screening of anti-polio virus activity of benzimidazole derivatives].
Otaki K; Inoue J; Yamazaki Z; Itaya M; Takai Y; Yasue M; Mizuno D
Yakugaku Zasshi; 1965 Oct; 85(10):926-35. PubMed ID: 4286119
[No Abstract] [Full Text] [Related]
20. Anti-viral activity of 5,6-dichloro-1-(2'-deoxy-beta-d-ribofuranosyl)benzimidazole and related derivatives.
Diwan A; Gowdy CN; Robins RK; Prusoff WH
J Gen Virol; 1968 Dec; 3(3):393-402. PubMed ID: 4304103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
